Main Session
Sep
28
PQA 02 - Lung Cancer/Thoracic Malignancies, Patient Reported Outcomes/QoL/Survivorship, Pediatric Cancer
2545 - Treatment Strategy for Potentially Resectable Stage III-N2 Driver Gene-Negative NSCLC in the Immunotherapy Era
Presenter(s)
Jiarui Zhao, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan,